Published in JAMA on August 28, 2002
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax (2004) 8.09
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA (2009) 5.32
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med (2008) 4.34
Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol Bull (2011) 4.27
Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med (2004) 3.12
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med (2014) 3.09
Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol (2012) 3.03
Inflammatory markers in population studies of aging. Ageing Res Rev (2010) 2.57
Vascular actions of estrogens: functional implications. Pharmacol Rev (2008) 2.52
Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ (2005) 1.90
Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr (2004) 1.88
A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun (2009) 1.88
Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery. Heart (2009) 1.62
Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med (2005) 1.55
Loss of ischaemic preconditioning in ovariectomized rat hearts: possible involvement of impaired protein kinase C epsilon phosphorylation. Cardiovasc Res (2008) 1.54
Effect of exercise training on chronic inflammation. Clin Chim Acta (2010) 1.52
Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab (2009) 1.49
Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol (2008) 1.44
"Shift-and-Persist" Strategies: Why Low Socioeconomic Status Isn't Always Bad for Health. Perspect Psychol Sci (2012) 1.42
Antagonistic characteristics are positively associated with inflammatory markers independently of trait negative emotionality. Brain Behav Immun (2008) 1.35
Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women. J Clin Endocrinol Metab (2008) 1.32
Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol (2008) 1.29
Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry (2014) 1.29
Income, education, and inflammation: differential associations in a national probability sample (The MIDUS study). Psychosom Med (2010) 1.28
Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat. J Cardiovasc Pharmacol (2011) 1.24
The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med (2008) 1.21
Inflammation and early-life abuse in women. Am J Prev Med (2012) 1.20
Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort. Gynecol Oncol (2012) 1.13
Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study. J Stroke Cerebrovasc Dis (2008) 1.13
Race and gender variation in response to evoked inflammation. J Transl Med (2013) 1.10
Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females. J Natl Med Assoc (2005) 1.05
The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure. J Am Coll Cardiol (2011) 1.04
Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences. Curr Cardiol Rev (2010) 1.04
Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women. J Endocrinol (2010) 1.02
Socioeconomic position, health behaviors, and C-reactive protein: a moderated-mediation analysis. Health Psychol (2010) 1.02
C-reactive protein is linked to lower cognitive performance in overweight and obese women. Inflammation (2008) 1.00
Hormone replacement therapy diminishes hearing in peri-menopausal mice. Hear Res (2009) 0.98
Circulating microparticles and endogenous estrogen in newly menopausal women. Climacteric (2009) 0.98
Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med (2013) 0.98
Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. Psychosom Med (2010) 0.98
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective. Curr Med Chem (2014) 0.96
Comparative insights into the regulation of inflammation: levels and predictors of interleukin 6 and interleukin 10 in young adults in the Philippines. Am J Phys Anthropol (2011) 0.95
Comparison of current guidelines for primary prevention of coronary heart disease: risk assessment and lipid-lowering therapy. J Gen Intern Med (2003) 0.94
Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologies. Drug Des Devel Ther (2009) 0.94
Health services research in the privacy age. J Gen Intern Med (2005) 0.93
Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle Study. Am J Epidemiol (2012) 0.93
A randomised controlled trial of a cognitive behavioural intervention for women who have menopausal symptoms following breast cancer treatment (MENOS 1): trial protocol. BMC Cancer (2011) 0.93
The prospective association of socioeconomic status with C-reactive protein levels in the CARDIA study. Brain Behav Immun (2012) 0.93
The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis. Arthritis Res Ther (2005) 0.91
Traffic-related exposures and biomarkers of systemic inflammation, endothelial activation and oxidative stress: a panel study in the US trucking industry. Environ Health (2013) 0.90
Human experimental endotoxemia in modeling the pathophysiology, genomics, and therapeutics of innate immunity in complex cardiometabolic diseases. Arterioscler Thromb Vasc Biol (2014) 0.88
Inflammation a possible link between economical stress and coronary heart disease. Eur J Epidemiol (2007) 0.87
Levels and determinants of inflammatory biomarkers in a Swiss population-based sample (CoLaus study). PLoS One (2011) 0.87
Long-term C-reactive protein variability and prediction of metabolic risk. Am J Med (2009) 0.87
The social patterns of a biological risk factor for disease: race, gender, socioeconomic position, and C-reactive protein. J Gerontol B Psychol Sci Soc Sci (2012) 0.85
Cardiovascular outcome ascertainment was similar using blinded and unblinded adjudicators in a national prospective study. J Clin Epidemiol (2010) 0.84
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Clin Cardiol (2009) 0.84
Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity. Am J Obstet Gynecol (2007) 0.84
Failure to consider the menstrual cycle phase may cause misinterpretation of clinical and research findings of cardiometabolic biomarkers in premenopausal women. Epidemiol Rev (2013) 0.84
Obstructive sleep apnea syndrome and cardiovascular disease: The influence of C-reactive protein. World J Exp Med (2015) 0.84
Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis. Atherosclerosis (2011) 0.83
Obesity and coronary microvascular disease - implications for adipose tissue-mediated remote inflammatory response. Curr Vasc Pharmacol (2014) 0.82
Effects of dietary isoflavones from Puerariae radix on lipid and bone metabolism in ovariectomized rats. Nutrients (2013) 0.82
Hormonal and nutritional effects on cardiovascular risk markers in young women. J Clin Endocrinol Metab (2007) 0.81
Metabolic biomarkers for predicting cardiovascular disease. Vasc Health Risk Manag (2013) 0.81
Changes in postmenopausal hormone therapy use since 1988. Womens Health Issues (2007) 0.81
Resampling Procedures for Making Inference under Nested Case-control Studies. J Am Stat Assoc (2013) 0.81
Aggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women. J Cardiovasc Pharmacol (2009) 0.81
Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes. Menopause (2011) 0.80
C-Reactive Protein Identifies Low-Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer-Norfolk Prospective Population Study. J Am Heart Assoc (2016) 0.79
Cardiometabolic risk among African American women: a pilot study. J Cardiovasc Nurs (2009) 0.78
Effect of the combined extracts of herba epimedii and fructus ligustri lucidi on sex hormone functional levels in osteoporosis rats. Evid Based Complement Alternat Med (2015) 0.78
Changes of High Sensitivity C-Reactive Protein During Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention. Res Cardiovasc Med (2015) 0.78
Is there an estrogenic component in the metabolic syndrome? Genes Nutr (2006) 0.77
Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine. Biomedicine (Taipei) (2015) 0.77
Multifactorial approach to the primary and secondary prevention of atherosclerosis. Ochsner J (2003) 0.76
Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients. Mediators Inflamm (2010) 0.76
Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy. MedGenMed (2006) 0.76
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial. Ecancermedicalscience (2008) 0.76
Chronic exposure to oral pathogens and autoimmune reactivity in acute coronary atherothrombosis. Autoimmune Dis (2014) 0.76
The relation between serum cytokine levels and common laboratory tests in healthy Japanese males. Environ Health Prev Med (2003) 0.76
Urinary lignans and inflammatory markers in the US National Health and Nutrition Examination Survey (NHANES) 1999-2004 and 2005-2008. Cancer Causes Control (2014) 0.76
Mediators and moderators of the effects of a year-long exercise intervention on endogenous sex hormones in postmenopausal women. Cancer Causes Control (2011) 0.76
The Role of Unknown Risk Factors in Myocardial Infarction. Cardiol Res (2010) 0.75
Dietary fatty acids and inflammatory markers in patients with coronary artery disease. Adv Biomed Res (2014) 0.75
Cytokine Patterns in Healthy Adolescent Girls: Heterogeneity Captured by Variable and Person-Centered Statistical Strategies. Psychosom Med (2016) 0.75
Association of Serum Sex Hormones with Hemostatic Factors in Women On and Off Hormone Therapy: The Multiethnic Study of Atherosclerosis. J Womens Health (Larchmt) (2015) 0.75
Cardiovascular biomarkers and their utility in the older adult. Curr Cardiovasc Risk Rep (2012) 0.75
Hormone replacement therapy and heart disease: the remains of the oestrogen hypothesis. Neth Heart J (2003) 0.75
Neutrophil-to-Lymphocyte Ratio for Risk Assessment in Coronary Artery Disease and Carotid Artery Atherosclerosis. J Cardiovasc Ultrasound (2016) 0.75
Individual assessment of arteriosclerosis by empiric clinical profiling. PLoS One (2007) 0.75
A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria. J Diabetes Res (2015) 0.75
Long-term treatment with budesonide/formoterol attenuates circulating CRP levels in chronic obstructive pulmonary disease patients of group D. PLoS One (2017) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Inflammation and atherosclerosis. Circulation (2002) 20.77
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32
Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30
Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med (2007) 14.90
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab (2010) 13.29
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09
Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50
Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06
Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA (2003) 10.05
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA (2007) 9.68
C-reactive protein levels and outcomes after statin therapy. N Engl J Med (2005) 9.47
Progress and challenges in translating the biology of atherosclerosis. Nature (2011) 9.41
A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med (2003) 9.24
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Estrogen therapy and coronary-artery calcification. N Engl J Med (2007) 8.70
Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA (2008) 8.44
The Women's Health Initiative recruitment methods and results. Ann Epidemiol (2003) 8.42
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med (2002) 7.77
Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med (2009) 7.62
Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46
A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care (2003) 7.40
C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33
Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA (2010) 7.12
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99
A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85
Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet (2009) 6.79
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med (2006) 6.58
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51
Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet (2009) 6.31
Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16
Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol (2009) 6.11
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol (2004) 6.08
Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med (2009) 6.00
Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med (2007) 5.95
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
C-reactive protein and the risk of developing hypertension. JAMA (2003) 5.75
Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA (2006) 5.75
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA (2005) 5.74
The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med (2006) 5.69